News - effusion
Global Markets for Coronary Stent Devices
24 May 2012, 5:31 am
NEW YORK, May 24, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Global Markets for Coronary Stent Devices http://www.reportlinker.com/p0801544/Global-Markets-for-Coronary-Stent-Devices.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Cardiovascular_DevicesINTRODUCTIONSTUDY ...
ICS may prevent parapneumonic effusion in patients with CAP
24 May 2012, 5:02 am
Prior treatment with inhaled corticosteroids in patients with respiratory disorders who develop community acquired pneumonia (CAP) is associated with a lower incidence and severity of parapneumonic
effusion, according to a new study from researchers in Spain.
Inhaled Cortocosteroids Reduce Pleural effusion in CAP
23 May 2012, 8:41 am
Prior treatment with inhaled corticosteroids in patients with respiratory disorders who develop community acquired pneumonia (CAP) is associated with a lower incidence and severity of parapneumonic
effusion, according to a new study from researchers in Spain.
Long-term ICS use reduces pleural effusion in patients with CAP
23 May 2012, 7:50 am
Prior treatment with inhaled corticosteroids in patients with respiratory disorders who develop community acquired pneumonia (CAP) is associated with a lower incidence and severity of parapneumonic
effusion, according to a new study from researchers in Spain.
Late-breaking clinical trials
22 May 2012, 1:55 pm
On Tuesday afternoon, May 22, 2012, results from seven late-breaking clinical trials will be presented in session C91 at the ATS International Conference. These studies examine treatments for ventilator-associated pneumonia, cardiac surgery associated kidney injury, septic shock, idiopathic pulmonary fibrosis, smoking cessation, malignant pleural
effusion and non-cystic fibrosis bronchiectasis.
Study Examines Treatments for Relieving Breathing Difficulties Among Patients with Lung effusions
20 May 2012, 10:25 am
Helen E. Davies, M.D., of the University Hospital of Wales, Cardiff, and colleagues compared the effectiveness of treatments to relieve breathing difficulties among patients with malignant pleural
effusion (presence of fluid in the pleural cavity [space between the outside of the lungs and the inside wall of the chest cavity], as a complication of malignant disease).
